GSA CAPITAL PARTNERS LLP - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 189 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,754
+65.8%
406,019
+152.9%
0.15%
+41.5%
Q2 2023$1,058
+78.4%
160,524
+83.8%
0.11%
+79.7%
Q1 2023$593
-36.0%
87,337
-30.3%
0.06%
-48.7%
Q4 2022$926
-99.8%
125,366
+141.7%
0.12%
+69.1%
Q3 2022$512,000
+59.0%
51,866
+82.1%
0.07%
+58.1%
Q1 2022$322,000
+13.4%
28,482
+57.4%
0.04%
+19.4%
Q4 2021$284,000
-21.8%
18,092
-18.3%
0.04%
-14.3%
Q4 2019$363,000
-48.0%
22,135
-57.9%
0.04%
-55.3%
Q3 2019$698,000
+123.7%
52,594
+340.3%
0.09%
+161.1%
Q4 2018$312,000
-16.1%
11,945
-26.3%
0.04%
+71.4%
Q3 2018$372,000
+60.3%
16,198
+11.4%
0.02%
+50.0%
Q4 2016$232,000
-21.6%
14,535
-18.4%
0.01%
-12.5%
Q3 2016$296,000
+13.4%
17,804
-42.9%
0.02%
-5.9%
Q1 2016$261,000
+17.6%
31,180
+30.8%
0.02%
+54.5%
Q4 2015$222,000
-62.6%
23,839
-54.7%
0.01%
-62.1%
Q3 2015$594,000
+147.5%
52,670
+255.2%
0.03%
+163.6%
Q2 2014$240,000
-46.3%
14,828
-46.2%
0.01%
-65.6%
Q1 2014$447,000
+299.1%
27,538
+169.7%
0.03%
+255.6%
Q3 2013$112,00010,2120.01%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders